LuminoMark Injection

· Hanlim Pharm. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LuminoMark Injection, covering 2019-06-06 to 2019-06-06. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions [Phase 2]